Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rhuleave-K
- Development stage
- Unknown
- Lead developer
- Arjuna Natural
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Rhuleave-K is a proprietary nutraceutical formulation developed by Arjuna Natural Pvt Ltd for the management of acute musculoskeletal pain and inflammation. It consists of a synergistic blend of *Curcuma longa* (turmeric) extract, *Boswellia serrata* extract (standardized to acetyl-11-keto-β-boswellic acid or AKBA), and cold-pressed black sesame seed oil. The formulation utilizes the patented SPEEDTECH technology to micronize botanical particles, enhancing bioavailability and ensuring a rapid onset of action, typically within 63 to 150 minutes. Rhuleave-K exerts its therapeutic effects by inhibiting the cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) enzymes, thereby reducing the production of pro-inflammatory mediators. It is marketed as a natural alternative to over-the-counter analgesics like acetaminophen and NSAIDs for conditions such as exercise-induced muscle soreness and posture-related low back pain.
- Brand names
- Rhuleave-K
02
Targets
PTGS2 (Prostaglandin-Endoperoxide Synthase 2)ALOX5 (Arachidonate 5-lipoxygenase)
Beyond the preview
Go deeper on Rhuleave-K.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rhuleave-K.